English | Español

Biospace
Patient Daily | Apr 10, 2026

AbbVie maintains confidence in Skyrizi after FDA approval of Icotyde for plaque psoriasis
Patient Daily | Apr 10, 2026

Takeda restructuring could affect more than 600 US employees, company says
Patient Daily | Apr 10, 2026

Lilly and Baseline investigate GLP-1 drugs for substance use disorders as research grows
Patient Daily | Apr 10, 2026

Kardigan blood pressure drug advances after mixed Phase 2 trial results
Patient Daily | Apr 10, 2026

FDA expected to make key drug approval decisions in second quarter of 2026
Patient Daily | Apr 10, 2026

Kevin Tang returns as Aurinia CEO with $50 million offer for Kezar Life Sciences
Patient Daily | Apr 10, 2026

Merck’s cholesterol pill shows strong results after FDA priority voucher
Patient Daily | Apr 10, 2026

Kailera Therapeutics files for IPO as biotech sector sees renewed activity

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures